The experts in Intrinsically Disordered Protein Drug Discovery
Drug design technology suitable for every protein target and molecular class.
NMR-AI drug screening
We leverage proprietary nuclear magnetic resonance (NMR) experiments at every stage of drug discovery, which are bolstered by our artificial intelligence (AI) and cheminformatics tools. These tools utilize 1D NMR screening data to boost AI-driven drug design and accelerate 3D structure calculations with our ML-based 4D NMR method. We can screen ~1500 compounds/day for binding to all kinds of proteins, including intrinsically disordered proteins (IDPs) and transmembrane proteins.
